Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Longeveron Inc (NQ: LGVN ) 2.350 -0.110 (-4.47%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 16, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Longeveron Inc < Previous 1 2 3 4 5 6 7 8 9 ... 11 12 Next > BioRestorative Therapies Presents Promising Data At Orthopaedic Research Society (ORS) 2024 Annual Meeting February 13, 2024 BioRestorative Therapies (NASDAQ: BRTX) is a clinical-stage biotech company that is developing cell-based therapies to treat chronic lumbar disc disease and metabolic conditions such as obesity and... Via Benzinga Longeveron (NASDAQ: LGVN) Making Inroads With Lomecel-B™ – Biotech’s Investigational Alzheimer’s Treatment Shows Positive Trial Results February 08, 2024 --News Direct-- Via News Direct Longeveron (NASDAQ: LGVN) Making Inroads With Lomecel-B™ – Biotech's Investigational Alzheimer's Treatment Shows Positive Trial Results February 07, 2024 Longeveron Inc. (NASDAQ: LGVN), a clinical-stage biotech company aiming to slow the effects of life-threatening and chronic aging-related conditions using cellular therapies, is making inroads with... Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session January 31, 2024 Via Benzinga Why Longeveron (LGVN) Shares Are Falling Sharply December 21, 2023 Longeveron Inc (NASDAQ: LGVN) shares are trading lower by 22.8% to $1.25 Thursday morning after the company has finalized an agreement for a Via Benzinga Earnings Preview: Longeveron November 09, 2023 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session January 30, 2024 Via Benzinga 12 Health Care Stocks Moving In Monday's Pre-Market Session January 29, 2024 Via Benzinga Lineage Cell Therapeutics, Longeveron And 2 Other Stocks Under $2 Insiders Are Buying January 03, 2024 The Dow Jones index closed higher by around 25 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... Via Benzinga Topics Stocks Exposures US Equities Nasdaq Gains 100 Points; CarMax Earnings Top Views December 21, 2023 U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining more than 100 points on Thursday. The Dow traded up 0.37% to 37,218.15 while the NASDAQ rose 0.73% to 14,885.76.... Via Benzinga Topics Stocks Exposures US Equities Why CarMax Shares Are Trading Higher By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session December 21, 2023 Shares of CarMax, Inc. (NYSE: KMX) moved higher during Thursday’s session following better-than-expected quarterly earnings. Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session December 21, 2023 Via Benzinga Crude Oil Moves Lower; Micron Issues Strong Forecast December 21, 2023 U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 100 points on Thursday. The Dow traded up 0.58% to 37,296.40 while the NASDAQ rose 0.77% to 14,891.87. The... Via Benzinga Topics Stocks Exposures Fossil Fuels US Equities 12 Health Care Stocks Moving In Wednesday's Pre-Market Session December 20, 2023 Via Benzinga Longeveron (NASDAQ: LGVN) Announces Positive Top-Line Results For Its Phase 2a Clinical Trial For The Treatment Of Mild Alzheimer’s Disease With Lomecel-B™ December 06, 2023 --News Direct-- Via News Direct 12 Health Care Stocks Moving In Tuesday's After-Market Session December 05, 2023 Via Benzinga Longeveron (NASDAQ: LGVN) Announces Positive Top-Line Results For Its Phase 2a Clinical Trial For The Treatment Of Mild Alzheimer's Disease with Lomecel-B™ December 05, 2023 Longeveron Inc. (NASDAQ: LGVN), a clinical-stage biotech company aiming to address life-threatening and chronic aging-related conditions using cell therapies, continues to make positive progress. Via Benzinga Earnings Scheduled For November 10, 2023 November 10, 2023 Companies Reporting Before The Bell • Dixie Gr (NASDAQ:DXYN) is estimated to report earnings for its third quarter. Via Benzinga Nearly A Third Of Japan’s 36 Million Seniors Are At Risk Of Aging Frailty – Could Lomecel-BTM, Longeveron’s (NASDAQ: LGVN) Cell Therapy Help? October 24, 2023 --News Direct-- Via News Direct Nearly A Third Of Japan's 36 Million Seniors Are At Risk Of Aging Frailty – Could Lomecel-BTM, Longeveron's (NASDAQ: LGVN) Cell Therapy Help? October 23, 2023 Nations all over the world are getting older, but Japan is leading the charge, with nearly a third of its total population over 65 — making Japan the oldest society in the world. Via Benzinga Does Bone Marrow Contain The Keys To Curing Alzheimer's? BioTech Announces Promising Results From Clinical Trial October 13, 2023 Wa’el Hashad, CEO of Longeveron (NASDAQ: LGVN), was a guest recently on Benzinga’s All-Access. Via Benzinga 12 Health Care Stocks Moving In Thursday's Pre-Market Session October 12, 2023 Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session October 09, 2023 Via Benzinga 12 Health Care Stocks Moving In Monday's Pre-Market Session October 09, 2023 Via Benzinga 12 Health Care Stocks Moving In Friday's Pre-Market Session October 06, 2023 Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session October 05, 2023 Via Benzinga Longeveron's Alzheimer's Candidate Meets Safety Goal In Mid-Stage Study October 05, 2023 Longeveron Inc (NASDAQ: LGVN) announced topline results from the Phase 2a trial of its investigational product Lomecel-B for Via Benzinga 12 Health Care Stocks Moving In Friday's Pre-Market Session September 15, 2023 Via Benzinga Why Accolade Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session October 05, 2023 Gainers Orchard Therapeutics plc (NASDAQ: ORTX) shares climbed 97.7% to $15.98 after the company agreed to be acquired by Japan's Kyowa Kirin for $16.00 per ADS in cash plus an additional contingent... Via Benzinga Roth MKM Analyst Projects An Impressive Price Target Of $15 Over The Next 12 Months For BioRestorative Therapies (NASDAQ: BRTX), Says "Low Valuation Undeserved" September 14, 2023 BioRestorative Therapies Inc. (NASDAQ: BRTX) (“BioRestorative”) is a clinical-stage biotech company that is developing cell-based therapies to treat chronic lumbar disc disease and metabolic conditions... Via Benzinga < Previous 1 2 3 4 5 6 7 8 9 ... 11 12 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.